Dean Wenham

Chief Executive Officer at InSynchrony Ventures, Inc.

Health Technology

Finance

Profile

Dean Wenham is the founder and CEO of InSynchrony Ventures, Inc., which was founded in 2016.
He is currently the Chief Executive Officer & Director at Aronnax International, Inc. and a Director at Cetya Therapeutics, Inc.

Dean Wenham active positions

Companies	Position	Start
InSynchrony Ventures, Inc. InSynchrony Ventures, Inc. Investment ManagersFinance InSynchrony Ventures Inc (InSynchrony Ventures) an investment vehicle of InSymbiosis International Inc is a venture capital firm founded in 2016 by Dr. Dean Wenham. The firm is headquartered in Montreal, Canada.	Chief Executive Officer	2015-12-31
Aronnax International, Inc. Aronnax International, Inc. BiotechnologyHealth Technology Aronnax International, Inc. provides pre-clinical drug discovery and development services. The company was founded in 2005 and is headquartered in Montreal, Canada.	Chief Executive Officer	-
Cetya Therapeutics, Inc. Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co.	Director/Board Member	-

All active positions of Dean Wenham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dean Wenham's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Cetya Therapeutics, Inc. Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co.	Health Technology
InSynchrony Ventures, Inc. InSynchrony Ventures, Inc. Investment ManagersFinance InSynchrony Ventures Inc (InSynchrony Ventures) an investment vehicle of InSymbiosis International Inc is a venture capital firm founded in 2016 by Dr. Dean Wenham. The firm is headquartered in Montreal, Canada.	Finance
Aronnax International, Inc. Aronnax International, Inc. BiotechnologyHealth Technology Aronnax International, Inc. provides pre-clinical drug discovery and development services. The company was founded in 2005 and is headquartered in Montreal, Canada.	Health Technology

See company connections